InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Rice William G., Chairman & CEO. Director active across 1 companies, notably Aptose Biosciences Inc.. Aggregated, 9 reports have been published. Total volume traded: €149k. The latest transaction was filed on 6 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€9,05510,000 shares@ €0.90550.23% mcap6.1% of flow
Common Shares
SEC:0001567619-22-012379:0·
Ideal exit: 3 Mar 2023 (T+270)
€17,74713,183 shares@ €1.34620.45% mcap25.3% of flow
Common Shares
SEC:0001567619-21-022227·
Ideal exit: 12 Sept 2022 (T+270)
€17,74713,183 shares@ €1.34620.45% mcap11.9% of flow
Common Shares
SEC:0001567619-21-022227:0·
Ideal exit: 12 Sept 2022 (T+270)
€17,72517,822 shares@ €0.99460.45% mcap25.3% of flow
Common Shares
SEC:0001567619-21-022080·
Ideal exit: 11 Sept 2022 (T+270)
€17,72517,822 shares@ €0.99460.45% mcap11.9% of flow
Common Shares
SEC:0001567619-21-022080:0·
Ideal exit: 11 Sept 2022 (T+270)
€17,8118,643 shares@ €2.06070.45% mcap25.4% of flow
Common Shares
SEC:0001567619-21-021215·
Ideal exit: 23 Aug 2022 (T+270)
€17,8118,643 shares@ €2.06070.45% mcap11.9% of flow
Common Shares
SEC:0001567619-21-021215:0·
Ideal exit: 23 Aug 2022 (T+270)
€16,8816,081 shares@ €2.77610.43% mcap24.1% of flow
Common shares
SEC:0001567619-21-013023·
Ideal exit: 29 Mar 2022 (T+270)
€16,8816,081 shares@ €2.77610.43% mcap11.3% of flow
Common shares
SEC:0001567619-21-013023:0·
Ideal exit: 29 Mar 2022 (T+270)
9 of 9 declarations
About Rice William G.
William G. Rice serves as Chairman, President & CEO of Aptose Biosciences Inc. In this role, he oversees the overall strategy and operations of the company. With extensive experience in the biopharmaceutical sector, William G. Rice is recognized for his ability to lead teams and develop innovative solutions. His commitment to operational excellence and shareholder value creation is central to his mission. William G. Rice plays a key role in guiding Aptose Biosciences Inc. towards sustainable growth.
